Blood clot risk with common IV catheters
Part of Heart & circulation clinical trials.
This study checks how often blood clots form in veins when patients have a common IV catheter for a week or more. By participating, you help doctors understand and prevent these clots.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are currently in a hospital, including ICU.
- You have a midline, PICC, or central line catheter.
- Your catheter has been in place for at least 7 days.
- You agree to have an ultrasound to check for clots.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how often people with a blood infection from a PICC or midline catheter also get a blood clot in the vein of their arm. The goal is to learn more about this problem so doctors can better prevent and treat it.
This study looks at why some people with interstitial lung disease develop blood clots while in the hospital. It may help doctors find ways to prevent these clots in the future.
This study follows people with a blood clot in the calf vein to learn how the clot changes over time using repeat ultrasound scans. It may help doctors understand who needs treatment and who can be watched safely.
This trial tests whether continuing a lower dose of blood thinners can prevent another blood clot in cancer patients who have had a clot in an arm or chest catheter. It may help find a safer way to prevent future clots.
This study tests two experimental drugs, REGN7508 and REGN9933, to see if they can safely prevent blood clots in the arm or chest in people who need a PICC line. If you are getting a PICC for treatments like chemotherapy or antibiotics, you may be able to join.
This trial tests whether starting enoxaparin (a blood-thinner) within 24 hours after placing a specific type of central line can prevent dangerous clots. It may help reduce clot risk in people whose line is placed in the neck or thigh vein, while also tracking bleeding side effects.
Hear when a new Thrombosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.